genprowebdirectory
Facebook
Linkedin
RSS
Twitter
Youtube
GEN Edge
Featured News
Multimedia
News
Insights
Topics
Artificial Intelligence
Bioprocessing
Cancer
Drug Discovery
Genome Editing
Infectious Diseases
OMICs
Translational Medicine
Magazine
Browse Issues
Subscribe
Multimedia
Summits
Webinars
GEN Live
Learning Labs
Podcasts
Resources
A-Lists
eBooks/Perspectives
Tutorials
Peer-Reviewed Journals
GEN Biotechnology
Re:Gen Open
New Products
Conference Calendar
Subscribe
Get GEN Magazine
Get GEN eNewsletters
Search
Facebook
Linkedin
RSS
Twitter
Youtube
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Privacy Policy
Password recovery
Recover your password
your email
A password will be e-mailed to you.
GEN – Genetic Engineering and Biotechnology News
GEN Edge
Featured News
Multimedia
News
Insights
Topics
Artificial Intelligence
Bioprocessing
Cancer
Drug Discovery
Genome Editing
Infectious Diseases
OMICs
Translational Medicine
Magazine
Browse Issues
Subscribe
Multimedia
Summits
Webinars
GEN Live
Learning Labs
Podcasts
Resources
A-Lists
eBooks/Perspectives
Tutorials
Peer-Reviewed Journals
GEN Biotechnology
Re:Gen Open
New Products
Conference Calendar
Subscribe
Get GEN Magazine
Get GEN eNewsletters
Home
2015
Abraxis BioScience
A-Lists
Top 20 Biopharma IPOs of January-June 2015
News
Sorrento Sells Cynviloq for $1.3B
Insights
Nanotechnology Enables Precise Cancer Targeting
Cancer
Abraxis Reports Phase III Success with Abraxane in First-Line NSCLC
Cancer
Abraxis Says NSCLC Phase III Trial Met Its Primary Endpoint
Bioprocessing
ProMetic and Abraxis Team Up to Develop New Applications of Prion-Capture Platform
News
Abraxis Divests Everything Except Abraxane Franchise to Spinout
News
NCCN to Explore Other Indications for Metastatic Breast Cancer Drug from Abraxis and AstraZeneca
News
Abraxis and ProMetic Bandy to Develop Four Biopharmaceuticals in Deal Valued at $321M
News
Abraxis and Scripps Ally to Advance Epothilone-Based Oncology Drugs
1
2
Page 1 of 2
Scroll Up
Scroll Up
